5:28 PM
 | 
Sep 09, 2013
 |  BC Extra  |  Financial News

DRI Capital closes $1.5 billion fund

DRI Capital closed its Drug Royalty III fund at $1.5 billion, above the firm's $1 billion target. DRI Capital acquires royalties from pharma and biotechs, research...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >